Last reviewed · How we verify
H5N1 pandemic influenza vaccine
H5N1 pandemic influenza vaccine is a Biologic drug developed by Seqirus. It is currently in Phase 2 development.
At a glance
| Generic name | H5N1 pandemic influenza vaccine |
|---|---|
| Sponsor | Seqirus |
| Modality | Biologic |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults (PHASE3)
- A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA) (PHASE1, PHASE2)
- A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults (PHASE1, PHASE2)
- Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial) (PHASE3)
- Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine Naïve Individuals (PHASE1)
- A Study of mRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy Adults (PHASE1, PHASE2)
- Safety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine. (PHASE1)
- A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects ≥18 Years of Age (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- H5N1 pandemic influenza vaccine CI brief — competitive landscape report
- H5N1 pandemic influenza vaccine updates RSS · CI watch RSS
- Seqirus portfolio CI
Frequently asked questions about H5N1 pandemic influenza vaccine
What is H5N1 pandemic influenza vaccine?
H5N1 pandemic influenza vaccine is a Biologic drug developed by Seqirus.
Who makes H5N1 pandemic influenza vaccine?
H5N1 pandemic influenza vaccine is developed by Seqirus (see full Seqirus pipeline at /company/seqirus).
What development phase is H5N1 pandemic influenza vaccine in?
H5N1 pandemic influenza vaccine is in Phase 2.
Related
- Manufacturer: Seqirus — full pipeline
- Compare: H5N1 pandemic influenza vaccine vs similar drugs
- Pricing: H5N1 pandemic influenza vaccine cost, discount & access